| Literature DB >> 22015093 |
Nada Vasic1, Ruza Stevic, Dragica Pesut, Dragana Jovanovic.
Abstract
Endoluminal brachytherapy for lung cancer ensures the delivery of a maximal therapeutic radiation dose to the tumor with a minimal effect on normal surrounding tissues. We report on a 62-year-old man, who acutely developed LBBB and heart failure 48 hours after the second course of combined endoluminal and external beam radiation therapy. After administration of angiotensin converting enzyme inhibitors, diuretics, and anti-inflammatory drugs, electrocardiographic changes resolved and patient completely recovered. Radiotherapy was reintroduced after ten days.Entities:
Mesh:
Substances:
Year: 2011 PMID: 22015093 DOI: 10.1016/S0954-6111(11)70016-6
Source DB: PubMed Journal: Respir Med ISSN: 0954-6111 Impact factor: 3.415